Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

gallium Ga 68-NOTA-MAL-Cys39-exendin-4

A radiopharmaceutical tracer composed of the glucagon-like peptide-1 receptor (GLP-1R) agonist exendin-4 in which the serine residues (ser39) are replaced with cysteine (cys39) linked by the macrocyclic chelating agent 1,4,7-triazacyclononane-N,N',N''-triacetic acid (NOTA), which is linked to maleimide (MAL), to the positron-emitting radionuclide gallium Ga 68, with potential use in diagnostic imaging upon positron emission tomography (PET)/computed tomography (CT). Upon administration of gallium Ga 68-NOTA-MAL-Cys39-exendin-4, the exendin-4 moiety binds to GLP-1R. The radionuclide moiety can be detected using PET/CT and GLP-1R-expressing tumors can be localized and visualized. GLP-1R, which is located on beta cells and regulates insulin secretion, is overexpressed on insulinomas, which are insulin-secreting neuroendocrine tumors (NETs).
Synonym:68 Ga-NOTA-MAL-Cys39-exendin-4
Search NCI's Drug Dictionary